Oventus is an Australian medical device company with a proprietary oral appliance for the treatment of sleep apnoea and snoring.

Oventus has released its first product, the O2vent™ Mono, in Australia and the funds raised by its IPO will be used to continue the commercialisation and distribution of this device in Australia, develop additional devices, as well as commence expansion into other markets. Oventus' medical devices are manufactured using 3D printing technology.

It is anticipated that OVN will list on the ASX during July 2016.